Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The results can last several months, but maintenance treatments are necessary to sustain the effects
En ensayos como SUSTAIN 6 y LEADER, se document una disminucin significativa en los eventos cardiovasculares adversos mayores (MACE) entre los pacientes tratados con semaglutida y liraglutida, en comparacin con los grupos placebo
Early reports from users point to better time-in-range, fewer extreme highs and lows, and in some cases, moderate weight loss
Bottom line: Semaglutide is evidence-based
Obesity is diagnosed when a persons body mass index (BMI) is 30 or higher, which is calculated based on the ratio of height to weight
Side effects requiring immediate medical attention include: Severe, persistent abdominal pain which may indicate pancreatitis (seek urgent medical care) Signs of gallbladder problems such as pain in the upper right abdomen, which can be common Severe allergic reactions (seek emergency care) Changes in vision, particularly in patients with diabetes The SmPC notes that in non-clinical studies, semaglutide caused thyroid C-cell tumours in rodents
